Allan E. David

4.7k total citations · 1 hit paper
64 papers, 3.8k citations indexed

About

Allan E. David is a scholar working on Biomaterials, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Allan E. David has authored 64 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Biomaterials, 25 papers in Molecular Biology and 25 papers in Biomedical Engineering. Recurrent topics in Allan E. David's work include Nanoparticle-Based Drug Delivery (30 papers), RNA Interference and Gene Delivery (16 papers) and Characterization and Applications of Magnetic Nanoparticles (16 papers). Allan E. David is often cited by papers focused on Nanoparticle-Based Drug Delivery (30 papers), RNA Interference and Gene Delivery (16 papers) and Characterization and Applications of Magnetic Nanoparticles (16 papers). Allan E. David collaborates with scholars based in United States, China and South Korea. Allan E. David's co-authors include Victor C. Yang, Beata Chertok, Adam J. Cole, Faquan Yu, Bradford A. Moffat, Brian D. Ross, Christian Bergemann, Craig J. Galbán, Yongzhuo Huang and Jianxin Wang and has published in prestigious journals such as Angewandte Chemie International Edition, ACS Nano and PLoS ONE.

In The Last Decade

Allan E. David

64 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors

2007 690 citations Beata Chertok, Bradford A. Moffat et al. Biomaterials profile →

Peers

Countries citing papers authored by Allan E. David

Since Specialization

Citations

This map shows the geographic impact of Allan E. David's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allan E. David with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allan E. David more than expected).

Fields of papers citing papers by Allan E. David

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allan E. David. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allan E. David. The network helps show where Allan E. David may publish in the future.

Co-authorship network of co-authors of Allan E. David

This figure shows the co-authorship network connecting the top 25 collaborators of Allan E. David. A scholar is included among the top collaborators of Allan E. David based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allan E. David. Allan E. David is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A review of design criteria for cancer-targeted, nanoparticle-based MRI contrast agents 2024 ·Applied Materials Today ·(unknown), Allan E. David	12
2	Nanomaterial Endocytosis: Quantification of Adsorption and Ingestion Mechanisms 2023 ·Magnetochemistry ·(unknown), Chen Zhou, Youngsok Choi, Allan E. David, Paul Todd, Thomas R. Hanley	4
3	Improving Cancer Targeting: A Study on the Effect of Dual-Ligand Density on Targeting of Cells Having Differential Expression of Target Biomarkers 2023 ·International Journal of Molecular Sciences ·(unknown), Allan E. David	7
4	Development and application of high-throughput screens for the discovery of compounds that disrupt ErbB4 signaling: Candidate cancer therapeutics 2020 ·PLoS ONE ·(unknown), (unknown), (unknown), John T. Piazza, (unknown), Kanupriya Whig, Ling Zhai, (unknown), (unknown), (unknown), (unknown), (unknown), Christopher P. Mill, (unknown), Forrest Smith, Mark J. Suto, Robert Bostwick, Ram B. Gupta, Allan E. David, David J. Riese	2
5	MRI-traceable theranostic nanoparticles for targeted cancer treatment 2020 ·Theranostics ·(unknown), (unknown), (unknown), Allan E. David	102
6	Evaluation of commercial soft contact lenses for ocular drug delivery: A review 2020 ·Acta Biomaterialia ·Xin Fan, (unknown), (unknown), R. C. Domszy, Naiping Hu, Arthur Yang, Allan E. David	49
7	A mouse model to investigate the impact of testosterone therapy on reproduction in transgender men 2019 ·Human Reproduction ·Hadrian M. Kinnear, (unknown), Allan E. David, Erica E. Marsh, Vasantha Padmanabhan, Ariella Shikanov, Molly B. Moravek	32
8	Development of a Durable Vapor Phase Deposited Superhydrophobic Coating for Steam Cycle Power Generation Condenser Tubes 2018 ·Journal of Thermal Science and Engineering Applications ·(unknown), Jie Zhong, Allan E. David, W. Robert Ashurst, Sushil H. Bhavnani, (unknown), (unknown)	5
9	Nanomaterial Endocytosis: Estimation of Particles Per Cell by Magnetic Measurement 2018 ·IEEE Magnetics Letters ·Zhou Chen, Youngsok Choi, Allan E. David, Paul Todd, Thomas R. Hanley	3
10	The Role of Membrane Asymmetry in Nanoparticle-Induced Plasma Membrane Damage 2018 ·Biophysical Journal ·(unknown), (unknown), Allan E. David, Amir M. Farnoud	1
11	PTD-Modified ATTEMPTS for Enhanced Toxin-based Cancer Therapy: An In Vivo Proof-of-Concept Study 2015 ·Pharmaceutical Research ·Meong Cheol Shin, Jian Zhang, Kyoung Ah Min, Huining He, Allan E. David, Yongzhuo Huang, Victor C. Yang	25
12	Cell Penetrating Peptides and the Mechanisms for Intracellular Entry 2014 ·Current Pharmaceutical Biotechnology ·Young Woo Choi, Allan E. David	42
13	The use of low molecular weight protamine chemical chimera to enhance monomeric insulin intestinal absorption 2013 ·Biomaterials ·Huining He, Jianyong Sheng, Allan E. David, Young Min Kwon, Jian Zhang, Yongzhuo Huang, Jianxin Wang, Victor C. Yang	59
14	Chemically and biologically synthesized CPP-modified gelonin for enhanced anti-tumor activity 2013 ·Journal of Controlled Release ·Meong Cheol Shin, Jian Zhang, Allan E. David, Wolfgang E. Trommer, Young Min Kwon, Kyoung Ah Min, Jin Hee Kim, Victor C. Yang	35
15	Magnetically-enabled and MR-monitored selective brain tumor protein delivery in rats via magnetic nanocarriers 2011 ·Biomaterials ·Beata Chertok, Allan E. David, Victor C. Yang	44
16	Synthetic Skin‐Permeable Proteins Enabling Needleless Immunization 2010 ·Angewandte Chemie International Edition ·Yongzhuo Huang, Yoon Shin Park, Cheol Moon, Allan E. David, Hee Soon Chung, Victor C. Yang	47
17	Substantiating in vivo magnetic brain tumor targeting of cationic iron oxide nanocarriers via adsorptive surface masking 2009 ·Biomaterials ·Beata Chertok, Allan E. David, Bradford A. Moffat, Victor C. Yang	46
18	Survival of human pre-antral follicles after cryopreservation of ovarian tissue, follicular isolation and in vitro culture in a calcium alginate matrix 2008 ·Human Reproduction ·Christiani A. Amorim, Anne Van Langendonckt, Allan E. David, Marie‐Madeleine Dolmans, (unknown)	171
19	Glioma selectivity of magnetically targeted nanoparticles: A role of abnormal tumor hydrodynamics 2007 ·Journal of Controlled Release ·Beata Chertok, Allan E. David, Yongzhuo Huang, Victor C. Yang	70
20	Strategies for improving the functionality of an affinity bioreactor 2005 ·International Journal of Pharmaceutics ·(unknown), Zhiqiang Yang, Emel Emregül, Allan E. David, Joseph P. Balthasar, Junfeng Liang, Victor C. Yang	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact